<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01266161</url>
  </required_header>
  <id_info>
    <org_study_id>B3491001</org_study_id>
    <secondary_id>AK-10-13</secondary_id>
    <nct_id>NCT01266161</nct_id>
  </id_info>
  <brief_title>Multiple Dose Dental Pain Study Of Ibuprofen Extended Release</brief_title>
  <official_title>A Multiple Dose Dental Pain Study Of An Ibuprofen 600 Mg Extended Release Caplet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that single and multiple doses of ibuprofen 600 mg ER caplets provide
      analgesic efficacy superior to placebo over 12-hour dosing intervals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sum of pain relief and pain intensity difference scores from 0-12 hours after the first dose (SPRID 0-12)</measure>
    <time_frame>0-12 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Sum of pain relief and pain intensity difference scores from 8-12 hours after the first dose</measure>
    <time_frame>8-12 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sum of pain intensity difference scores 0-12, 8-12, 12-24, 20-24, 0-24, 24-36, 32-36, 36-48, 44-48, and 24-48 hours</measure>
    <time_frame>0-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first rescue medication for the first dose</measure>
    <time_frame>0-12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects taking rescue medication after the first dose, and overall</measure>
    <time_frame>0-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain relief (PR) at individual time points up to 12 hours</measure>
    <time_frame>0-12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity difference (PID) socres at individual time points up to 48 hours</measure>
    <time_frame>0-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain relief combined with pain intensity difference (PRID) socres at individual time points up to 12 hours</measure>
    <time_frame>0-12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-weighted sum of pain relief scores from 0-12 and 8-12 hours (TOTPAR 0-12 and 8-12)</measure>
    <time_frame>0-12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects taking rescue medication in each dosing interval (except the first dose as noted above)</measure>
    <time_frame>12-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount (number of doses) of rescue medication used (overall and in each dosing interval)</measure>
    <time_frame>0-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first perceptible relief confirmed by meaningful relief</measure>
    <time_frame>0-12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to meaningful relief</measure>
    <time_frame>0-12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Times to rescue medication over the entire study</measure>
    <time_frame>0-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global evaluations at 24 and 48 hours (or at the time of first use of rescue medication during each day)</measure>
    <time_frame>0-48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen 600 mg extended release</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 600 mg ER</intervention_name>
    <description>One 600 mg caplet dosed at 0, 12, 24 and 36 hours</description>
    <arm_group_label>Ibuprofen 600 mg extended release</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One placebo caplet dosed at times 0, 12, 24 and 36 hours</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females 16 to 40 years of age

          -  Subjects who undergo surgical removal of at least two third molars

          -  One of which must be a partial or full bony mandibular impaction

          -  Subjects must have at least moderate baseline pain (a score of 2 on the categorical
             pain severity rating scale) confirmed by a score of at least 50 mm on the 100-mm
             visual analog scale-pain severity rating scale (VAS-PSR)

        Exclusion Criteria:

          -  Acute localized dental infection at the time of surgery that could confound the
             post-surgical evaluation

          -  Presence or history of any significant organ disease

          -  Use of prescription or OTC first generation antihistamines

          -  Females who are pregnant, lactating or of childbearing potential and not using a
             medically approved method to prevent pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B3491001&amp;StudyName=Multiple%20Dose%20Dental%20Pain%20Study%20Of%20Ibuprofen%20Extended%20Release</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2010</study_first_submitted>
  <study_first_submitted_qc>December 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2010</study_first_posted>
  <disposition_first_submitted>April 19, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>April 19, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">April 24, 2012</disposition_first_posted>
  <last_update_submitted>April 19, 2012</last_update_submitted>
  <last_update_submitted_qc>April 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dental pain</keyword>
  <keyword>multiple dose</keyword>
  <keyword>ibuprofen</keyword>
  <keyword>third molar extraction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 20, 2013</submitted>
    <returned>March 29, 2013</returned>
    <submitted>May 24, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

